تولید مواد اولیه داروپخش

دتماد | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:

داروهای شیمیایی و گیاهی

Market Type:

Stocks

Status:

Authorized

Last Price: 58,820 2.99
Close Price: 58,180

Financial Ratios

2026/07/07
Fiscal Year 2026/03/2012 Month
2025/05/18
Fiscal Year 2025/03/2012 Month
2024/05/16
Fiscal Year 2024/03/1912 Month

Net Profit to Sales

39.9230.5131.35

Gross Profit to Sales

47.6937.5438.02

Operating Margin

50.4940.5441.6

Gross Profit to Sales

47.9442.3544.71

Net Profit to Gross Profit

83.2772.0370.11

Return on Assets (ROA)

27.4316.6726.17

Return on Capital (%)

444.79935.55842.76

Return on Equity (ROE)

75.2536.3283.42

Working Capital Return

87.190.92107.74

Fixed Asset Return

390.657.2286.54

Loan Benefit Assessment

2.742.183.19

Current Ratio

1.521.351.37

Quick Ratio

1.10.90.88

Liquidity Ratio

0.110.120.04

Net Working Capital

14,298,2477,357,5695,593,060

Current Assets Ratio

0.920.710.9

Inventory Turnover

235.1244.52199.25

Receivables Collection Period

252.24221.98179.63

Inventory to Working Capital

0.81.291.33

Working Capital Turnover

2.182.983.44

Fixed Asset Turnover

9.791.889.14

Total Asset Turnover

0.690.550.83

Debt Ratio

0.640.540.69

Debt to Equity

1.741.182.19

Long-Term Debt to Equity

0.070.040.08

Current Debt to Equity

1.671.142.11

Equity Ratio

36.4545.9131.37

Debt Coverage Ratio

2.5915.123.63